BioMap
AI-based precision medicine supporting tool for drug discovery
📍 Beijing, china
About This Fund
BioMap is a corporate investor (Cheminformatics,) founded in 2020 and headquartered in Beijing, china. AI-based precision medicine supporting tool for drug discovery. The company has developed software that uses AI technology for research and development. It has features for multi-omic data analysis, drug designing, and more. Practice areas include Life Sciences and HealthTech. The firm operates as Life Sciences Tech and Genomics. Key investment sectors include Artificial Intelligence.
Investment Focus
Sectors
Stages
Check Size
Not disclosed
Geography
Preparing to pitch BioMap?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →